Medtherapy Biotechnology (India) Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 6.83 Cr
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 20.00 Cr
About Medtherapy Biotechnology (India)
Medtherapy Biotechnology (India) Private Limited (MBIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 18 February 2020 (Four years and 11 months 26 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 6.83 Cr.
The company currently has active open charges totaling ₹20.00 Cr.
Bikash Verma and Vijayabhaskar Kandula serve as directors at the Company.
Company Details
-
Location
Ghaziabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24110UP2020FTC170983
-
Company No.
362006
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
18 Feb 2020
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Medtherapy Biotechnology (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bikash Verma
|
Director | 18-Feb-2020 | Current |
Vijayabhaskar Kandula
|
Director | 18-Feb-2020 | Current |
Financial Performance of Medtherapy Biotechnology (India).
Medtherapy Biotechnology (India) Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medtherapy Biotechnology (India)?
In 2021, Medtherapy Biotechnology (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Global Center For Gene Therapies FoundationBikash Verma and Vijayabhaskar Kandula are mutual person
Charges (Loans)
₹20.00 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 20.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Aug 2024 | State Bank Of India | ₹20.00 Cr | Open |
How Many Employees Work at Medtherapy Biotechnology (India)?
Unlock and access historical data on people associated with Medtherapy Biotechnology (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medtherapy Biotechnology (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medtherapy Biotechnology (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.